C. Warren Olanow
- Neurology top 0.01%
- Parkinson's Disease Mechanisms and Treatments 216
- Neurological disorders and treatments 158
- Botulinum Toxin and Related Neurological Disorders 27
- Neurological diseases and metabolism 20
- Cellular and Molecular Neuroscience top 0.01%
- Nuclear Receptors and Signaling 38
- Genetic Neurodegenerative Diseases 35
- Nerve injury and regeneration 28
- Neurology top 0.05%
- Parkinson's Disease Mechanisms and Treatments 216
- Neurological disorders and treatments 158
- Botulinum Toxin and Related Neurological Disorders 27
- Neurological diseases and metabolism 20
- Developmental Neuroscience top 0.1%
- Physiology top 0.2%
-
- Autism Spectrum Disorder Research 26
- Co-authors
- Jeffrey H. KordowerJosé Á. ObesoDaniel P. PerlThomas B. FreemanKevin St. P. McNaughtRobert A. HauserW. G. TattonFabrizio Stocchi
- Partner nations
- United StatesItalyCanada
In The Last Decade
C. Warren Olanow
299 papers receiving 39.7k citations
Hit Papers
Peers
Comparison fields: 5 of 197
- Neurology 26.9k
- Cellular and Molecular Neuroscience 15.7k
- Neurology 4.7k
- Developmental Neuroscience 1.8k
- Physiology 5.5k
Countries citing papers authored by C. Warren Olanow
This map shows the geographic impact of C. Warren Olanow's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C. Warren Olanow with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C. Warren Olanow more than expected).
Fields of papers citing papers by C. Warren Olanow
This network shows the impact of papers produced by C. Warren Olanow. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C. Warren Olanow. The network helps show where C. Warren Olanow may publish in the future.
Co-authorship network
The 25 scholars most cited alongside C. Warren Olanow, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 5 | |
| 2 | 2020 | 15 | |
| 3 | 2018 | 1 | |
| 4 | Safinamide – A New Therapeutic Option to Address Motor Symptoms and Motor Complications in Mid- to Late-stage Parkinson’s Disease | 2016 | 7 |
| 5 | MDS clinical diagnostic criteria for Parkinson's diseasebreakdown → | 2015 | 4841 |
| 6 | Targeting α-synuclein for treatment of Parkinson's disease: mechanistic and therapeutic considerationsbreakdown → | 2015 | 388 |
| 7 | 2014 | 341 | |
| 8 | 2012 | 45 | |
| 9 | 2009 | 49 | |
| 10 | Lewy body–like pathology in long-term embryonic nigral transplants in Parkinson's diseasebreakdown → | 2008 | 1240 |
| 11 | 2008 | 68 | |
| 12 | 2003 | 22 | |
| 13 | 2002 | 211 | |
| 14 | 2002 | 200 | |
| 15 | 2000 | 5 | |
| 16 | The role of comt inhibitors in the treatment of Parkinson's disease | 2000 | 1 |
| 17 | 2000 | 172 | |
| 18 | 1999 | 211 | |
| 19 | 1996 | 12 | |
| 20 | Oxidative stress and the pathogenesis of Parkinson's diseasebreakdown → | 1996 | 815 |
About C. Warren Olanow
C. Warren Olanow is a scholar working on Neurology, Cellular and Molecular Neuroscience and Neurology, having authored 303 papers that have together received 40.6k indexed citations. Recurring topics across this work include Parkinson's Disease Mechanisms and Treatments (216 papers), Neurological disorders and treatments (158 papers), Nuclear Receptors and Signaling (38 papers), Genetic Neurodegenerative Diseases (35 papers), Nerve injury and regeneration (28 papers), Botulinum Toxin and Related Neurological Disorders (27 papers), Autism Spectrum Disorder Research (26 papers) and Neurological diseases and metabolism (20 papers). The work is most often cited by research in Neurology (26.9k citations), Cellular and Molecular Neuroscience (15.7k citations) and Neurology (4.7k citations). C. Warren Olanow has collaborated with scholars based in United States, Italy and Canada. Frequent co-authors include Jeffrey H. Kordower, José Á. Obeso, Daniel P. Perl, Thomas B. Freeman, Kevin St. P. McNaught, Robert A. Hauser, W. G. Tatton, Fabrizio Stocchi, Christopher G. Goetz and Yaping Chu. Their work appears in journals such as Movement Disorders, Annals of Neurology, Neurology, The Lancet Neurology and Clinical Neuropharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.